Vifor Pharma in US$100m licence deal with Cara Therapeutics
Vifor Pharma and Cara Therapeutics have signed a US license agreement for Korsuva to treat dialysis patients with pruritus.
Author Archive for: TG
About Thomas Gabrielczyk
This author has yet to write their bio.Meanwhile lets just say that we are proud Thomas Gabrielczyk contributed a whooping 449 entries.
Entries by Thomas Gabrielczyk
Atriva Therapeutics gets 24m from EIB
20th October 2020 in News /by Thomas GabrielczykAtriva Therapeutics has secured a 24m loan to push the development of its COVID-19 programme ATR-002, an antiviral, anti-inflammatory MEK inhibitor.
Topas raises 22m in Series B financining
19th October 2020 in News /by Thomas GabrielczykTopas Therapeutics GmbH will use the 22m proceeds from a Series B Financing to advance two pipeline candidates.
Siemens launches COVID-19 antigen lateral flow test
14th October 2020 in News /by Thomas GabrielczykSiemens Healthineers has launched its Clinitest Rapid COVID-19 Antigen Test in Europe, which can identify persons infected with SARS-CoV-2 in 15 minutes.
Priothera closes 30m Series A financing
13th October 2020 in News /by Thomas GabrielczykPriothera Ltd. wants to use 30m from a Series A financing to develop a licenced therapy for acute myeloid leukemia (AML).
COVID-19 jab: EU signs contract with JNJ
9th October 2020 in News /by Thomas GabrielczykJohnson & Johnson (JNJ) has inked a contract with the European Commission to supply 200 million doses of its COVID-19 vaccine to the European Union.
Santhera ends development of idebenone
6th October 2020 in News /by Thomas GabrielczykSwiss Santhera Pharmaceuticals has discontinued Phase III development of its DMD drug and will restructure its pipeline.
Nobel Prize in Physiology for HCV pioneers
5th October 2020 in News /by Thomas GabrielczykThe Nobel Prize in Physiology or Medicine goes to Harvey J. Alter, Michael Houghton and Charles M. Ric
Swiss Sophia Genetics to expand globally
2nd October 2020 in News /by Thomas GabrielczykSwiss Sophia Genetics has raised $110m, to expand marketing of its AI-driven cancer and genetic disease decision support platform globally.
EIB and EC launch circular bioeconomy fund
1st October 2020 in News /by Thomas GabrielczykThe European Commission (EC) and the European Investment Bank (EIB) have launched a circular bioeconomy fund with a target size of 250m. ·